Autor: |
Manterola L; Molecular Oncology Group, Biodonostia Research Institute, San Sebastián, Gipuzkoa, Spain., Aguirre P; Department of Pathology, Donostia University Hospital, San Sebastián, Gipuzkoa, Spain., Larrea E; Molecular Oncology Group, Biodonostia Research Institute, San Sebastián, Gipuzkoa, Spain., Arestín M; Molecular Oncology Group, Biodonostia Research Institute, San Sebastián, Gipuzkoa, Spain., Gaafar A; Department of Pathology, Cruces University Hospital, Barakaldo, Bizkaia, Spain., Elorriaga K; Department of Pathology, Onkologikoa, San Sebastian, Gipuzkoa, Spain., Goicoechea I; Molecular Oncology Group, Biodonostia Research Institute, San Sebastián, Gipuzkoa, Spain., Armesto M; Molecular Oncology Group, Biodonostia Research Institute, San Sebastián, Gipuzkoa, Spain., Fernández-Mercado M; Molecular Oncology Group, Biodonostia Research Institute, San Sebastián, Gipuzkoa, Spain., Zabalza I; Department of Pathology, Galdakao-Usansolo Hospital, Galdakao, Bizkaia, Spain., López-Duque JC; Department of Pathology, Basurto University Hospital, Bilbao, Bizkaia, Spain., Larruskain E; Department of Otolaryngology, Donostia University Hospital, San Sebastián, Gipuzkoa, Spain., Sistiaga JA; Department of Otolaryngology, Donostia University Hospital, San Sebastián, Gipuzkoa, Spain., Landa M; Department of Otolaryngology, Donostia University Hospital, San Sebastián, Gipuzkoa, Spain., Zabala A; Department of Otolaryngology, Basurto University Hospital, Bilbao, Bizkaia, Spain., Santaolalla F; Department of Otolaryngology, Basurto University Hospital, Bilbao, Bizkaia, Spain., Municio JA; Department of Otolaryngology, Cruces University Hospital, Barakaldo, Bizkaia, Spain., Ispizua Á; Department of Otolaryngology, Donostia University Hospital, San Sebastián, Gipuzkoa, Spain., García-Pedrero JM; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto Universitario de Oncología del Principado de Asturias, University of Oviedo, CIBERONC, Oviedo, Asturias, Spain., Rodrigo JP; Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto Universitario de Oncología del Principado de Asturias, University of Oviedo, CIBERONC, Oviedo, Asturias, Spain., Lawrie CH; Molecular Oncology Group, Biodonostia Research Institute, San Sebastián, Gipuzkoa, Spain. charles.lawrie@biodonostia.org.; Radcliffe Department of Medicine, University of Oxford, Oxford, UK. charles.lawrie@biodonostia.org.; IKERBASQUE, Basque Foundation for Science, Bilbao, Bizkaia, Spain. charles.lawrie@biodonostia.org. |